EHA Library - The official digital education library of European Hematology Association (EHA)

HODGKIN'S LYMPHOMA AND AUTOIMMUNE DISEASES
Author(s): ,
Benhabiles Rym
Affiliations:
ALGIERS,ALGERIA,ALGIERS,Algeria
,
FAIZA TALBI
Affiliations:
ALGIERS,ALGERIA,ALGIERS,Algeria
,
SALAH EDDINE BELAKEHAL
Affiliations:
ALGIERS,ALGERIA,ALGIERS,Algeria
,
S CHAIB
Affiliations:
ALGIERS,ALGERIA,ALGIERS,Algeria
,
Nadjet Demmane Debbih
Affiliations:
ALGIERS,ALGERIA,ALGIERS,Algeria
FATMA ZOHRA ARDJOUN
Affiliations:
ALGIERS,ALGERIA,ALGIERS,Algeria
(Abstract release date: 05/19/16) EHA Library. Rym B. 06/09/16; 134951; PB2051
Dr. Benhabiles Rym
Dr. Benhabiles Rym
Contributions
Abstract
Abstract: PB2051

Type: Publication Only

Background
Hodgkin's lymphoma (HL) is a tumor disease of the lymphoid tissue characterized by presence of Reed-Sternberg cells. Autoimmune phenomena are associated with HL. They may precede the clinical presentation of HL, occur concurrently or later, either spontaneously or following treatment. The relationship between HL and autoimmune diseases has been reported as bi-directional, however there is a few data in general population. 

Aims
Evaluation of the percentage of autoimmune diseases associated with HL on a retrospective study of 80 cases.

Methods
A retrospective study in the hematology department, conducted over a period of 5 years (from 2008 to 2012), which concerned 80 cases of HL.The diagnosis is histological completed with immunohistochemistry using anti CD15 and anti CD30 anibody. Patients are classified according to the classification of Ann Arbor.We used prognostic classifications : the EORTC for localized stages and IPS for advanced stages.A clinical assessment is performed and includes: blood glucose, renal assessment, liver function tests, viral serology, a respiratory functional exploration, electrocardiogram and echocardiography. Patients are treated with ABVD chemotherapy associated with mantle radiotherapy.In front of presence of warning signs ( palpitations, dyspnea, asthenia, bone pain, thrombosis ) an immunological assessment is carried out in search of lupus anticoagulant, anticardiolipin, anti-histone antibodies, anti-nuclear factor, thyroid function tests (TSH, FT3, FT4, ATG, ATPO), cervical ultrasound.Biopsies are sometimes carried out in the context and the type of autoimmune disease and sought by the existence of clinically detectable lesions (biopsy of the salivary glands, skin …).

Results
Eighty cases were included, 5 (6,2%) of which, had an autoimmune disease diagnosed previously, simultaneously or after lymphoma. There are 4 women and 1 man. Autoimmune diseases were: lupus erythematosus, thyroiditis autoimmune, celiac disease, sarcoidosis.The diagnosis was made after lymphoma in 4 patients and before in 1 patient,no deaths were registered.
PatientAntecedentsHistological typeStageTreatmentOutcomeAuto-immune disease typeDelays occuredTreatmentDecline
1Thyroiditis autoimmune (hypothyroidism 3 years before diagnosis in Levothyrox)1II Aa3 ABVD+RadiotherapyComplete remissionlupus erythematosus :Lupus anticoagulant +, anti histone +, cardiolipin +3months after diagnosisSteroids5 years
2Absent2I Aa3 ABVD + RadiotherapyComplete remissionthyroiditis autoimmune : TSH collapsedlow FT4high ATPOhigh ACTG10 months after RxTLevothyrox3 years
3Absent2I Aa4 ABVD + RadiotherapyComplete remissionthyroiditis autoimmune : low TSH high-TPO2 months after RxTLevothyrox1 year
4Celiac disease since the age of 6 years2IIIBb4 ABVD + RadiotherapyComplete remissionCeliac disease17 years before diagnosisdiet without gluten6 years
5Absent2II Ba3 ABVD + RadiotherapyComplete remissionSarcoidosis : converting enzyme / CT mediastinal biopsy of the salivary glands and skin25 months after diagnosisCorticosteroid (restrictive pattern)4 year


Conclusion
HL association with an autoimmune disease is estimated at 6.2%. There was an important prevalence of autoimmune diseases in girls with HL.The contribution of the activity of the autoimmune disease and immunosuppressive drugs in the development of HL is still not understood. It might be interesting to try to define a population at risk, by personal or family history of autoimmunity and regular and rigorous monitoring of patients during and after treatment with unusual clinical and biological signs.

Session topic: E-poster
Abstract: PB2051

Type: Publication Only

Background
Hodgkin's lymphoma (HL) is a tumor disease of the lymphoid tissue characterized by presence of Reed-Sternberg cells. Autoimmune phenomena are associated with HL. They may precede the clinical presentation of HL, occur concurrently or later, either spontaneously or following treatment. The relationship between HL and autoimmune diseases has been reported as bi-directional, however there is a few data in general population. 

Aims
Evaluation of the percentage of autoimmune diseases associated with HL on a retrospective study of 80 cases.

Methods
A retrospective study in the hematology department, conducted over a period of 5 years (from 2008 to 2012), which concerned 80 cases of HL.The diagnosis is histological completed with immunohistochemistry using anti CD15 and anti CD30 anibody. Patients are classified according to the classification of Ann Arbor.We used prognostic classifications : the EORTC for localized stages and IPS for advanced stages.A clinical assessment is performed and includes: blood glucose, renal assessment, liver function tests, viral serology, a respiratory functional exploration, electrocardiogram and echocardiography. Patients are treated with ABVD chemotherapy associated with mantle radiotherapy.In front of presence of warning signs ( palpitations, dyspnea, asthenia, bone pain, thrombosis ) an immunological assessment is carried out in search of lupus anticoagulant, anticardiolipin, anti-histone antibodies, anti-nuclear factor, thyroid function tests (TSH, FT3, FT4, ATG, ATPO), cervical ultrasound.Biopsies are sometimes carried out in the context and the type of autoimmune disease and sought by the existence of clinically detectable lesions (biopsy of the salivary glands, skin …).

Results
Eighty cases were included, 5 (6,2%) of which, had an autoimmune disease diagnosed previously, simultaneously or after lymphoma. There are 4 women and 1 man. Autoimmune diseases were: lupus erythematosus, thyroiditis autoimmune, celiac disease, sarcoidosis.The diagnosis was made after lymphoma in 4 patients and before in 1 patient,no deaths were registered.
PatientAntecedentsHistological typeStageTreatmentOutcomeAuto-immune disease typeDelays occuredTreatmentDecline
1Thyroiditis autoimmune (hypothyroidism 3 years before diagnosis in Levothyrox)1II Aa3 ABVD+RadiotherapyComplete remissionlupus erythematosus :Lupus anticoagulant +, anti histone +, cardiolipin +3months after diagnosisSteroids5 years
2Absent2I Aa3 ABVD + RadiotherapyComplete remissionthyroiditis autoimmune : TSH collapsedlow FT4high ATPOhigh ACTG10 months after RxTLevothyrox3 years
3Absent2I Aa4 ABVD + RadiotherapyComplete remissionthyroiditis autoimmune : low TSH high-TPO2 months after RxTLevothyrox1 year
4Celiac disease since the age of 6 years2IIIBb4 ABVD + RadiotherapyComplete remissionCeliac disease17 years before diagnosisdiet without gluten6 years
5Absent2II Ba3 ABVD + RadiotherapyComplete remissionSarcoidosis : converting enzyme / CT mediastinal biopsy of the salivary glands and skin25 months after diagnosisCorticosteroid (restrictive pattern)4 year


Conclusion
HL association with an autoimmune disease is estimated at 6.2%. There was an important prevalence of autoimmune diseases in girls with HL.The contribution of the activity of the autoimmune disease and immunosuppressive drugs in the development of HL is still not understood. It might be interesting to try to define a population at risk, by personal or family history of autoimmunity and regular and rigorous monitoring of patients during and after treatment with unusual clinical and biological signs.

Session topic: E-poster

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies